BeiGene Announces Clinical Data to Be Presented at the Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)

NEXT STORY
Roche’s Tecentriq as a first-line monotherapy helped certain people with advanced non-small cell lung cancer live longer compared with chemotherapy
PREV STORY
Beroni Group Launches its First-Ever Japan-Made Stem Cell Based Regenerative Skincare Products in the Rapidly Growing Chinese Consumer Market
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis data at ASCO and EHA showcase bold approaches to reimagine cancer and blood disorders through multiple therapeutic platforms

author_avatar
NASDAQ Market News

Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma Multiforme and Collaboration with GCAR for Potential Inclusion in GBM AGILE Clinical Trial

author_avatar
NASDAQ Market News

Y-mAbs Announces Data to be Presented at 2020 ASCO Annual Meeting

author_avatar
NASDAQ Market News